Erika Szántó
Abstract
The effects of naproxen 250 mg b.i.d. and indomethacin 50 mg t.i.d. were compared in 21 patients with classical or definite RA. The study was designed as a randomized, double-blind crossover.
OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The effects of naproxen 250 mg b.i.d. and indomethacin 50 mg t.i.d. were compared in 21 patients with classical or definite RA. The study was designed as a randomized, double-blind crossover.
Key concepts: Medicine, Naproxen, Rheumatoid arthritis, Double blind, Crossover study, Gastroenterology, Internal medicine, Randomized controlled trial